Sign up
Log in
This GATX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Share
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Jefferies analyst Jonathan Petersen initiated coverage on Iron Mountain Incorporated (NYSE:IRM) with a Buy rating and announced a price target of $120. Iron Mountain shares closed at $99.89 on Friday. See how other analysts view this stock.
  • Citigroup analyst Ben Mohr initiated coverage on GATX Corporation (NYSE:GATX) with a Buy rating and announced a price target of $201. GATX shares closed at $172.07 on Friday. See how other analysts view this stock.
  • Evercore ISI Group analyst Elizabeth Suzuki initiated coverage on Humana Inc. (NYSE:HUM) with an In-Line rating and announced a price target of $295. Humana shares closed at $252.66 on Friday. See how other analysts view this stock.
  • Goldman Sachs analyst Salveen Richter initiated coverage on Immunome, Inc. (NASDAQ:IMNM) with a Buy rating and announced a price target of $26. Immunome shares closed at $9.39 on Friday. See how other analysts view this stock.
  • GLJ Research analyst Austin Wang initiated coverage on Argan, Inc. (NYSE:AGX) with a Hold rating and announced a price target of $251. Argan shares closed at $260.64 on Friday. See how other analysts view this stock.

Considering buying GATX stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.